Christian Beckmann, Sander Leeuwenburgh and Annette Schenck each receive an 1.5 million euro Vici research grant from the Netherlands Organisation for Scientific Research (NWO). The recipients will use the money to conduct research over the next five years and build up their own research group. The Vici grant is one of the largest personal scientific grants of the Netherlands. This year, the NWO awarded 32 Vici grants in total (seven Vici grants for Radboud University medical center and University).
Christian Beckmann, DCMN, theme Stress-related disorders.
Big data for precision medicine: new tools for brain connectopics.
Christian Beckmann is appointed as professor Statistical Imaging Neuroscience. His research focus is on developing novel methods for imaging neurosciences. Over the last two decades neuroimaging has made significant contributions to our understanding of human brain function. The indirect nature of the data requires sophisticated modeling and analysis approaches in order to infer interpretable quantities of interest.
The researcher will develop techniques that allow researchers to better understand human brain processes and compare individual patients to ‘normal’ ranges of cognitive functioning. These techniques will be tested in a large Dutch sample of early Parkinson’s Disease patients to better understand the underlying neurobiology of the disorder.
Sander Leeuwenburgh, RIMLS, theme Reconstructive and regenerative medicine.
Regeneration of diseased bone by biomaterials built from nanoparticles.
Sander Leeuwenburgh is professor Regenerative Biomaterials. His research group is developing injectable and self-healing biomaterials which stimulate the regenerative capacity of the human body.
Currently available biomaterials are not able to heal defects in diseased bone effectively. In this project novel self-porous and healing biomaterials will be self-assembled from nanoparticles to release antibacterial and anticancer drugs directly into cells. These new properties will accelerate bone regeneration and combat bone diseases effectively.
Annette Schenck: DCMN, theme Neurodevelopmental disorders.
Towards treatment of Intellectual Disability and Autism disorders.
Annette Schenck is Associate Professor in Translational Genomics of Neurodevelopmental Disorders. Her research focuses on dissecting molecular networks and mechanisms underlying human brain function and disease. In order to be able to investigate the large number of genes, we use a powerful genetic model organism, the fruitfly Drosophila melanogaster.
Intellectual disability and autism are frequent and currently untreatable disorders. This project will use an ancient, highly conserved form of learning and the fruit fly as a model to investigate the neurobiology of these disorders and develop effective translational treatment strategies for subgroups of patients.
Related news items
The Postdoctoral Networking Tour in artificial intelligence2 July 2020
You are a postdoctoral researcher in the field of artificial intelligence? The Postdoc-NeT-AI offers you the opportunity to participate in one week of on-site visits to leading German universities, research institutes and companies. Apply now to this year's tour until 16 August 2020.read more
Register for Phd courses via gROW What does this mean for you?2 July 2020
From now on you can arrange everything related to the general RU PhD courses via gROW. Because of this there will be some changes in the registration! What does this mean for you?read more
Experts on metabolic diseases still an unknown major problem...1 July 2020
Six Dutch UMCs and a patient association contribute to treating and solving this major, often unknown, problem. Timely detection of metabolic diseases is vital. Therefore, Radboudumc is also part of the consortium “United for Metabolic Diseases”.read more
Radboud Pluim for Lionne Ekers ambassador for the RIMLS institute30 June 2020
Lionne Ekers received the Radboudpluim for her special merits for the Radboudumc. She is a born ambassador for our Institute.read more
Stefan Listl member Lancet Commission on Oral Health29 June 2020
In recognition of the global public health importance, woeful neglect of oral diseases, and the need for a broader understanding and commitment to global oral health within medicine and global health agendas, The Lancet recently established a Commission on Oral Health.read more
Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection29 June 2020
In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2.read more